Mather Group
PCVX icon

Mather Group’s Vaxcyte PCVX Stock Holding History

Mather Group’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.68K Buy
+65
New +$3.79K ﹤0.01% 1888

Other funds holding PCVX

BG Investment Services
BG Investment Services Hagatna, Guam $673M AUM 14.41% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
Avior Wealth Management
Avior Wealth Management Omaha, Nebraska $3.79B AUM 15.36% 1-Year Est. Return
Values First Advisors
Values First Advisors Gray, Tennessee $213M AUM 20.51% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return
Teza Capital Management
Teza Capital Management Chicago, Illinois $112M AUM 57.58% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Mather Group's PCVX Position: Q3 2026 in Review

Mather Group opened a new position in Vaxcyte (PCVX) in Q3 2026: 65 shares worth $3.68K. The stake represents ﹤0.01% of the portfolio and ranks #1888 among its holdings.

44 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • Mather Group held 65 shares of Vaxcyte worth $3.68K as of Q3 2026.
  • Vaxcyte was a new Mather Group position in Q3 2026.
  • Vaxcyte made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1888 holding.
  • 44 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.